Canada · Delayed Price · Currency is CAD Diagnamed Holdings Statistics
Total Valuation
CSE:DMED has a market cap or net worth of CAD 10.48 million. The enterprise value is 10.22 million.
| Market Cap | 10.48M |
| Enterprise Value | 10.22M |
Important Dates
The next estimated earnings date is Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:DMED has 110.28 million shares outstanding. The number of shares has increased by 8.05% in one year.
| Current Share Class | 110.28M |
| Shares Outstanding | 110.28M |
| Shares Change (YoY) | +8.05% |
| Shares Change (QoQ) | +19.48% |
| Owned by Insiders (%) | 17.42% |
| Owned by Institutions (%) | n/a |
| Float | 90.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -107.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75
| Current Ratio | 0.75 |
| Quick Ratio | 0.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -270.60% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1,084.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +350.00% in the last 52 weeks. The beta is -1.12, so CSE:DMED's price volatility has been lower than the market average.
| Beta (5Y) | -1.12 |
| 52-Week Price Change | +350.00% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 53.07 |
| Average Volume (20 Days) | 910,904 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.06M |
| Pretax Income | -1.13M |
| Net Income | -1.13M |
| EBITDA | n/a |
| EBIT | -1.06M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 261,464 in cash and n/a in debt, giving a net cash position of 261,464 or 0.00 per share.
| Cash & Cash Equivalents | 261,464 |
| Total Debt | n/a |
| Net Cash | 261,464 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -97,893 |
| Book Value Per Share | -0.00 |
| Working Capital | -97,893 |
Cash Flow
| Operating Cash Flow | -278,787 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:DMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.05% |
| Shareholder Yield | -8.05% |
| Earnings Yield | -10.81% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |